8515 M (Flecainide 150 mg)
Pill imprint 8515 M has been identified as Flecainide acetate 150 mg.
Flecainide is used in the treatment of atrial fibrillation; atrial flutter; paroxysmal supraventricular tachycardia; supraventricular tachycardia; wolff-parkinson-white syndrome (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 8515 M
- Strength:
- 150 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-8515
More about flecainide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 89 Reviews – Add your own review/rating
- Drug class: group I antiarrhythmics
Consumer resources
Other brands: Tambocor
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
